Screening of group B Streptococcus infection in pregnancy and neonatal outcomes in the province of Trento, Italy.

Group B streptococcus infection birth attendance certificate neonatal infection pregnancy universal screening

Journal

Le infezioni in medicina
ISSN: 2532-8689
Titre abrégé: Infez Med
Pays: Italy
ID NLM: 9613961

Informations de publication

Date de publication:
2022
Historique:
received: 08 03 2022
accepted: 06 05 2022
entrez: 13 6 2022
pubmed: 14 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

The study analyzes the trend of group B streptococcal (GBS) infection in pregnancy in the province of Trento, Italy, where a universal screening of GBS infection in pregnancy has been active for some time. Data from pregnant women who gave birth at local maternity units between 2015-2019 were obtained from birth attendance certificates (BAC), the main - and mandatory - source of information for monitoring pregnancies, births and neonatal health in Italy. The BAC used in the province of Trento acquires the results of a vast range of infections in pregnancy. The data collected from the BAC were integrated with those provided by the Hospital Information System (SIO). The occurrence of neonatal GBS infection was investigated on 2019 birth cohort, using the hospital discharge archive as an ancillary information source. Between 2015-2019, 20,905 pregnant women received care at maternity units of the province of Trento, Italy, of whom 25.5% were foreigners. The average coverage of GBS testing in pregnancy was 91.8% (95% CI 91.25-92.35) without significant variations from one year to the next. Test coverage varies in relation to maternity units and some socio-demographic characteristics of mothers. The average proportion of GBS positive cases over the study period was 21.0% (95% CI 20.7-21.3), a value that does not show statistically significant changes from one year to the next. The proportion of positive cases appears uneven among the subgroups of pregnant women considered, even if the differences are not statistically significant. In the 2019 birth cohort, newborns to GBS-positive mothers had an excess of stillbirths, of those born with Apgar at 5 minutes <7 and hospitalized at birth. However, these excesses were not statistically significant. Intravenous Antibiotic Prophylaxis (IAP) was performed in 86.8% of births from GBS positive mothers who had an indication for IAP. IAP was inadequate in 7.4% of the GBS positive mothers. Postnatal evaluation of 783 live births to GBS positive mothers identified 3 cases of early neonatal GBS infection. The incidence of neonatal GBS infection over the whole series of live births is 0.71/1,000 (95% CI 0.56-0.86), 0.68/1000 (CI 95% 0.55-0.79) in Italians and 1.07/1000 (95% CI 0.45-1.65) in foreigners. Data collection on infections in pregnancy through BAC allows area-based assessment. The quality of the data recorded in the BAC can be considered satisfactory but it was necessary to access to other information sources. The local availability of various information sources should allow periodic audits and closer monitoring of neonatal GBS infection.

Identifiants

pubmed: 35693054
doi: 10.53854/liim-3002-11
pii: 1124-9390_30_2_2022_254-262
pmc: PMC9177189
doi:

Types de publication

Journal Article

Langues

eng

Pagination

254-262

Informations de copyright

Copyright © 2016 - 2022 InfezMed.

Déclaration de conflit d'intérêts

Conflicts of interest None

Références

Pediatr Infect Dis J. 2017 Jul;36(7):665-669
pubmed: 28027278
Rev Soc Bras Med Trop. 2017 Mar-Apr;50(2):179-183
pubmed: 28562753
Ann Ist Super Sanita. 2013;49(4):370-5
pubmed: 24334782
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD007467
pubmed: 19588432
J Pediatr Nurs. 2004 Oct;19(5):357-63
pubmed: 15614260
Lancet. 2004 Jan 24;363(9405):292-4
pubmed: 14751704
MMWR Recomm Rep. 1996 May 31;45(RR-7):1-24
pubmed: 8637497
Acta Obstet Gynecol Scand. 2008;87(3):260-71
pubmed: 18307064
J Obstet Gynaecol Res. 2016 Nov;42(11):1471-1475
pubmed: 27558911
Obstet Gynecol. 2020 Feb;135(2):e51-e72
pubmed: 31977795
J Matern Fetal Neonatal Med. 2019 Jun;32(12):2049-2055
pubmed: 29343192
Pediatrics. 2007 Sep;120(3):e487-93
pubmed: 17766492
J Med Screen. 2011;18(2):60-4
pubmed: 21852697
Pediatrics. 2006 Jun;117(6):e1139-45
pubmed: 16682492
J Clin Pathol. 2007 Oct;60(10):1140-3
pubmed: 17182659
MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22
pubmed: 12211284
J Obstet Gynaecol. 2014 Nov;34(8):673-8
pubmed: 24921191
Pediatrics. 2013 Feb;131(2):e361-8
pubmed: 23296441
PLoS One. 2016 Nov 18;11(11):e0166179
pubmed: 27861568
Lancet. 1999 Jan 2;353(9146):51-6
pubmed: 10023965
Clin Infect Dis. 2000 Feb;30(2):276-81
pubmed: 10671328
N Engl J Med. 2002 Jul 25;347(4):233-9
pubmed: 12140298
Ital J Pediatr. 2014 Feb 22;40:23
pubmed: 24559197
J Matern Fetal Neonatal Med. 2016 Mar;29(6):911-5
pubmed: 25758622
Pediatrics. 2019 Oct;144(4):
pubmed: 31570651
Semin Fetal Neonatal Med. 2011 Oct;16(5):254-8
pubmed: 21493170
MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36
pubmed: 21088663
Expert Rev Anti Infect Ther. 2015;13(11):1387-99
pubmed: 26295167
Pediatr Infect Dis J. 2014 Dec;33(12):1211-5
pubmed: 25037035
J Pediatr. 2013 Aug;163(2):568-73
pubmed: 23477995
PLoS One. 2017 Aug 15;12(8):e0183083
pubmed: 28813477
J Matern Fetal Neonatal Med. 2015 May;28(7):766-82
pubmed: 25162923
PLoS One. 2017 Jul 5;12(7):e0180262
pubmed: 28678829
Klin Lab Diagn. 2016 Feb;61(2):107-10
pubmed: 27455565

Auteurs

Silvano Piffer (S)

Clinical and Evaluational Epidemiology Service. Provincial Health Agency, Trento, Italy.

Roberto Rizzello (R)

Clinical and Evaluational Epidemiology Service. Provincial Health Agency, Trento, Italy.

Mariangela Pedron (M)

Clinical and Evaluational Epidemiology Service. Provincial Health Agency, Trento, Italy.

Laura Dellanna (L)

Obstetrics and Gynaecology Unit, Ospedale S. Chiara Trento. Provincial Health Agency, Trento, Italy.

Anna Lina Lauriola (AL)

Paediatrics Unit, Ospedale S. Maria del Carmine, Rovereto. Provincial Health Agency, Trento, Italy.

Classifications MeSH